Novartis AG is 1.3x more valuable than GSK plc by market capitalization ($283.13 B vs $221.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVS | GSK |
|---|---|---|
| Market cap | $283.13 B | $221.53 B |
| US-listed rank | #47 | #62 |
| SEC filings | 947 | 988 |
Novartis AG is 1.3x more valuable than GSK plc by market capitalization ($283.13 B vs $221.53 B).
Full pages: Novartis AG and GSK plc, or browse the full rankings.